Involvement of HIV-1 protease in virus-induced cell killing

Antiviral Research

Volumn 66, Issue 1, 2005, Pages 47-55

  Ventoso, Iván ^a   Navarro, Joaquín ^b   Munoz Ma A ^b   Carrasco, Luis ^a  

^a UNIVERSIDAD AUTÓNOMA DE MADRID   (Spain)

^b HOSPITAL GENERAL UNIVERSITARIO GREGORIO MARAÑÓN   (Spain)

Author keywords

Apoptosis; Cell lysis; Cytopathogenicity; HIV 1 protease; Saquinavir

Indexed keywords

OKT 4; PROTEINASE; PROTEINASE INHIBITOR; SAQUINAVIR; VIRUS ENZYME; ZIDOVUDINE;

APOPTOSIS; ARTICLE; CELL KILLING; CELL SURVIVAL; CONTROLLED STUDY; CYTOLYSIS; DRUG EFFECT; DRUG INHIBITION; DRUG TARGETING; ENZYME ACTIVATION; ENZYME ASSAY; ENZYME INHIBITION; ENZYME SPECIFICITY; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LYMPHOCYTE COUNT; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN TARGETING; REINFECTION; T LYMPHOCYTE; VIRUS REPLICATION; VIRUS STRAIN;

HUMAN IMMUNODEFICIENCY VIRUS 1;

EID: 15244359897     PISSN: 01663542     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.antiviral.2004.12.008     Document Type: Article

References (42)

1. A. Adachi, H.E. Gendelman, S. Koenig, T. Folks, R. Willey, A. Rabson, and M.A. Martin Production of acquired immunodeficiency syndrome-associated retrovirus in human and nonhuman cells transfected with a infectious molecular clone J. Virol. 59 1986 284 291
2. P. Ashorn, T.J. McQuade, S. Thaisrivongs, A.G. Tomasselli, W.G. Tarpley, and B. Moss An inhibitor of the protease blocks virus maduration of human and simian immunodeficiency virus and spread of infection Proc. Natl. Acad. Sci. U.S.A. 87 1990 7472 7476
3. V. Ayyavoo, A. Mahboubi, S. Mahalingam, R. Ramalingam, S. Kudchodkar, W.V. Williams, D.R. Green, and D.B. Weiner HIV-1 Vpr suppresses immune activation and apoptosis through regulation of nuclear factor κB Nat. Med. 3 1997 1117 1123
4. A. Bergamini, L. Dini, M. Cappozzi, L. Ghibelli, R. Placido, E. Faggioli, A. Salanitro, E. Buonanno, L. Cappannoli, L. Ventura, M. Cepparulo, L. Falasca, and G. Rocchi Human immunodeficiency virus-induced cell death in cytokine-treated macrophages can be prevented by compounds that inhibit late stages of viral replication J. Infect. Dis. 173 1996 1367 1378
5. R. Blanco, L. Carrasco, and I. Ventoso Cell killing by HIV-1 protease J. Biol. Chem. 278 2003 1086 1093
6. S.T. Butera, B.D. Roberts, L. Lam, T. Hodge, and T.M. Folks Human immunodeficiency virus type 1 RNA expression by four chronically infected cell lines indicates multiple mechanisms of latency J. Virol. 68 1994 2726 2730
7. J. Cao, I.-W. Park, A. Cooper, and J. Sodroski Molecular determinants of acute single-cell lysis by human immunodeficiency virus type 1 J. Virol. 70 1996 1340 1354
8. + cells Proc. Natl. Acad. Sci. U.S.A. 97 2000 1178 1183
9. A.G. Fisher, L. Ratner, H. Mitsuya, L.M. Marselle, M.E. Harper, S. Broder, R.C. Gallo, and F. Wong-Staal Infectious mutants of HTLV-III with changes in the 3′region and markedly reduced cytopathic effects Science 233 1986 655 659
10. T.M. Folks, K.A. Clouse, J. Justement, A. Rabson, E. Duh, J.H. Kehrl, and A.S. Fauci Tumor necrosis factor a induces expression of human immunodeficiency virus in a chronically infected T-cell clone Proc. Natl. Acad. Sci. U.S.A. 86 1989 2365 2368
11. + T cells by a Fas-independent mechanism J. Exp. Med. 187 1998 1113 1122
12. B. Hirschel, and M. Opravil The year in review: antiretroviral treatment AIDS 13 1999 177 187
13. D.D. Ho, A.U. Neumann, A.S. Perelson, W. Chen, J.M. Leonard, and M. Markowitz Rapid turnover of plasma virions and CD4 lymphocytes in HIV-1 infection Nature 373 1995 123 126
14. A.H. Kaplan, M. Manchester, and R. Swanstrom The activity of the protease of human immunodeficiency virus type 1 is initiated at the membrane of infected cells before the release of viral proteins and is required for release to occur with maximum efficiency J. Virol. 68 1994 6782 6786
15. A.H. Kaplan, and R. Swanstrom Human immunodeficiency virus type 1 Gag proteins are processed in two cellular compartments Proc. Natl. Acad. Sci. U.S.A. 88 1991 4528 4532
16. V. Kolesnitchenko, L. King, A. Riva, Y. Tani, S.J. Korsmeyer, and D.I. Cohen A major human immunodeficiency virus type 1-initiated killing pathway distinct from apoptosis J. Virol. 71 1997 9753 9763
17. J. Konvalinka, M.A. Litterst, R. Welker, H. Kottler, F. Rippmann, A.M. Heuser, and H.G. Krausslich An active-site mutation in the human immunodeficiency virus type 1 proteinase (PR) causes reduced PR activity and loss of PR-mediated cytotoxicity without apparent effect on virus maturation and infectivity J. Virol. 69 1995 7180 7186
18. H.-G. Kräusslich Specific inhibitor of human immunodeficiency virus proteinase prevents the cytotoxic effects of a single-chain proteinase dimer and restores particle formation J. Virol. 66 1992 567 572
19. J.A. Labonte, T. Patl, W. Hofmann, and J. Sodroski Importance of membrane fusion mediated by human immunodeficiency virus envelope glycoproteins for lysis of primary CD4-positive T cells J. Virol. 74 2000 10690 10698
20. M. Leist, B. Single, A.F. Castoldi, S. Kühnle, and P. Nicotera Intracellular adenosine triphosphate (ATP) concentration: a switch in the decision between apoptosis and necrosis J. Exp. Med. 185 1997 1481 1485
21. W. Lu, and J.-M. Andrieu HIV protease inhibitors restore impaired T-cell proliferative response in vivo and in vitro: a viral-suppression-independent mechanism Blood 96 2000 250 258
22. + T cells in vitro. Differential induction of apoptosis in these cells J. Immunol. 152 1994 330 342
23. + T-cell depletion in HIV disease Nature 410 2001 974 979
24. T.J. McQuade, A.G. Tomasselli, L. Liu, V. Karacostas, B. Moss, T.K. Sawyer, R.L. Heinrikson, and W.G. Tarpley A synthetic human immunodeficiency virus protease inhibitor with potent anti-viral activity arrest HIV-like particle maduration Science 247 1990 454 456
25. L. Meyaard, S.O. Otto, R.R. Jonker, M.J. Mijnster, R.P. Keet, and F. Miedema Programmed death of T cells in HIV-1 infection Science 257 1992 217 219
26. U. O'Doherty, W.J. Swiggard, and M.H. Malim Human immunodeficiency virus type 1 spinoculation enhances infection through virus binding J. Virol. 74 2000 100074 100080
27. J.M. Orenstein In vivo cytolysis and fusion of human immunodeficiency virus type 1-infected lymphocytes in lymphoid tissue J. Infect. Dis. 182 2000 338 342
28. B.N. Phenix, J.B. Angel, F. Mandy, S. Kravcik, K. Parato, K.A. Chambers, K. Gallicano, N. Hawley-Foss, S. Cassol, D.W. Cameron, and A.D. Badley Decreased HIV-1-associated T cell apoptosis by HIV protease inhibitors AIDS Res. Hum. Retroviruses 16 2000 559 567
29. B.N. Phenix, J.J. Lum, Z. Nie, J. Sanchez-Dardon, and A.D. Bradley Antiapoptotic mechanism of HIV protease inhibitors: preventing mitochondrial transmembrane potential loss Blood 98 2001 1078 1085
30. D.R. Plymale, D.S. Tang, A.M. Comardelle, C.D. Fermin, D.E. Lewis, and R.F. Garry Both necrosis and apoptosis contribute to HIV-1-induced killing of CD4 cells AIDS 13 1999 1827 1830
31. D.R. Plymale, A.M. Comardelle, C.D. Fermi, D.S. Martin, J.M. Costin, C.H. Norris, S.B. Tencza, T.A. Mietzner, R.C. Montelaro, and R.F. Garry Concentration-dependent differential induction of necrosis or apoptosis by HIV-1 lytic peptide Peptides 20 1999 1275 1283
32. B. Poon, K. Grovit-Ferbas, S.A. Stewart, and I.S.Y. Chen Cell cycle arrest by Vpr in HIV-1 virions and insensitivity to antiretroviral agents Science 281 1998 266 268
33. M.E. Rogel, L.I. Wu, and M. Emerman The human immunodeficiency virus type 1 Vpr gene prevents cell proliferation during chronic infection J. Virol. 69 1995 882 888
34. S. Rowland-Jones, S. Pinheiro, and R. Kaul New insights into host factors in HIV-1 pathogenesis Cell 104 2001 473 476
35. C. Scheller, and C. Jassoy Syncytium formation amplifies apoptotic signals: a new view on apoptosis in HIV infection in vitro Virology 282 2001 48 55
36. J.M. Seamus, C.P.M. Reutelingsperger, A.J. McGahon, J.A. Rader, R.C.A. Van Schie, D.M. LaFace, and D.R. Grenn Early redistribution of plasma membrane phosphatidylserine is a general feature of apoptosis regardless of the initiating stimulus: Inhibition by overexpression of Bcl-2 and Abl J. Exp. Med. 182 1995 1545 1556
37. R.L. Shoeman, B. Höner, T.J. Stoller, C. Kesselmeier, M.C. Miedel, P. Traub, and M.C. Graves Human immunodeficiency virus type 1 protease cleaves the intermediate filament proteins vimentin, desmin, and glial fibrillary acidic protein Proc. Natl. Acad. Sci. U.S.A. 87 1990 6336 6340
38. M. Somasundaran, and H.L. Robinson A major mechanism of human immunodeficiency virus-induced cell killing does not involve cell fusion J. Virol. 61 1987 3114 3119
39. M. Somasundaran, and H.L. Robinson Unexpectedly high levels of HIV-1 RNA and protein synthesis in a cytocidal infection Science 242 1988 1554 1557
40. P.R. Strack, M.W. Frey, C.J. Rizzo, B. Cordova, H.J. George, R. Meade, S.P. Ho, J. Corman, R. Tritch, and B.D. Korant Apoptosis mediated by HIV protease is preceded by cleavage of Bcl-2 Proc. Natl. Acad. Sci. U.S.A. 93 1996 9571 9576
41. Ch. Terai, R.S. Kornbluth, C.D. Pauza, D.D. Richman, and D.A. Carson Apoptosis as a mechanism of cell death in cultured T lymphoblasts acutely infected with HIV-1 J. Clin. Invest. 87 1991 1710 1715
42. I. Ventoso, R. Blanco, C. Perales, and L. Carrasco HIV-1 protease cleaves eukaryotic initiation factor 4G and inhibits cap-dependent translation Proc. Natl. Acad. Sci. U.S.A. 98 2001 12966 12971